TuHURA Biosciences, Inc. secures $12.5 million in a private equity financing to advance cancer immunotherapy treatments, with an additional $3.0 million from warrant exercises.
Amount Raised
$12.5 Million
Round Type
Private Equity
TampaBiotechnologyHealthcareHealth CareTherapeuticsDescription
TuHURA Biosciences, Inc. has announced a definitive securities purchase agreement to issue $12.5 million in common stock through a private placement. The offering includes cash proceeds and warrant exercises totaling $3.0 million. The capital will help advance their pipeline of treatments to overcome resistance to cancer immunotherapy.
Who to call at TuHURA Biosciences, and when
A new round usually means TuHURA Biosciences is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day TuHURA Biosciences raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at TuHURA Biosciences, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at TuHURA Biosciences. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment TuHURA Biosciences raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
TuHURA Biosciences raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.